Form 4: Tenaya Therapeutics CEO Faraz Ali Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Faraz Ali sold 3,189 shares of Tenaya Therapeutics common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 16, 2025, Faraz Ali, CEO of Tenaya Therapeutics, Inc. (TNYA), sold 3,189 shares of common stock.
- The sale was executed at a price of $0.4427 per share.
- This transaction was to cover tax withholding obligations related to the vesting of restricted stock units awarded on February 6, 2025.
- Following the transaction, Ali directly owns 317,325 shares, which includes 259,568 shares issuable upon the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes on vested stock), so the sentiment is neutral.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of restricted stock units award |
| 05/16/2025 | Date of stock sale transaction |
Keywords
Form 4, Tenaya Therapeutics, TNYA, Faraz Ali, CEO, stock sale, restricted stock units, tax withholding, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.